Conditional ERK3 overexpression cooperates with PTEN deletion to promote lung adenocarcinoma formation in mice
S. Vallabhaneni, J. Liu, M. Morel, W. Wang, F. J. Demayo, W. Long
Molecular Oncology · Dec 14, 2021Peer-reviewedCancer Biology
Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
6 papers
Recent·Most cited
S. Vallabhaneni, J. Liu, M. Morel, W. Wang, F. J. Demayo, W. Long
Molecular Oncology · Dec 14, 2021Peer-reviewedCancer Biology
X. Zhou, J. W. Li, Z. Chen, W. Ni, X. Li, R. Yang, H. Shen, J. Liu, F. J. DeMayo, J. Lu, F. J. Kaye, L. Wu
This study shows that CRTC-CREB activation drives LKB1-null lung cancer growth and identifies it as a therapeutic target.
bioRxiv · Jan 9, 2021Cancer Biology
E. A. McGlade, G. G. Herrera, K. K. Stephens, S. L. Olsen, S. Winuthayanon, J. Guner, S. C. Hewitt, K. S. Korach, F. J. DeMayo, J. P. Lydon, D. Monsivais, W. Winuthayanon
This study investigates how estrogen affects different cell types in mouse oviducts using scRNA-seq and identifies Igf1 as an estrogen-target gene linked to fertility.
bioRxiv · Dec 18, 2020Cell Biology
X. Wang, J. Wendel, R. E. Emerson, R. R. Broaddus, C. J. Creighton, D. Rusch, A. M. Buechlein, F. J. DeMayo, J. P. Lydon, S. Hawkins
This paper shows that deleting Pten and Dicer1 in mice leads to poorly-differentiated endometrial adenocarcinoma with molecular features similar to human DICER1-mutant cancers.
bioRxiv · Mar 12, 2020 · PreprintCancer Biology
M. Wetendorf, R. Li, S.-P. Wu, J. Liu, C. J. Creighton, T. Wang, K. S. Janardhan, C. J. Wilson, R. B. Lanz, B. D. Murphy, J. P. Lydon, F. J. DeMayo
This study shows that overexpression of PGRB promotes ovarian tumor development in mice, while PGRA reduces tumor frequency, highlighting the role of PGR isoforms in hormone-dependent neoplasia.
bioRxiv · Oct 24, 2019Cancer Biology
H. Alam, M. Tang, M. Maitituoheti, S. S. Dhar, S. Amin, B. Gu, T.-Y. Chen, Y.-H. Lin, J. Chen, F. Muller, F. J. DeMayo, L. Baseler, K. Rai, M. Lee
The paper shows that MLL4 loss in lung cancer promotes glycolysis and that inhibiting glycolysis selectively targets MLL4-mutant lung tumors.
bioRxiv · Dec 28, 2018 · PreprintCancer Biology